Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
School of Medical Device, Shenyang Pharmaceutical University, Shenyang, China.
J Ethnopharmacol. 2024 Jan 10;318(Pt A):116909. doi: 10.1016/j.jep.2023.116909. Epub 2023 Jul 13.
Ulcerative colitis (UC) is an idiopathic intestinal disease characterized by chronic inflammation with unknown etiology. Kuijieling decoction is a traditional Chinese Medicine with unique therapeutic efficacy for UC.
To validate the effects of Kuijieling decoction on vitamin A metabolism and retinoic acid (RA) production, along with evaluation of its immunomodulatory activity, and further clarify the upstream mechanisms underlying Treg/Th17 regulation that contribute to therapeutic effects against UC.
Network pharmacology and molecular docking analyses were employed to predict the potential anti-UC targets of Kuijieling and associated pathways. A rat model of UC was generated by treatment with trinitrobenzene sulfonic acid (TNBS) to induce inflammation. T lymphocytes were induced to differentiate into Th17 via combined stimulation with the cytokines TGF-β1, IL-6 and IL-23. Expression levels of RA/RARα-related factors (RARα, CRABPII, Smad3, IL-6R and IL-23R) and Treg/Th17 cell-related factors (Foxp3, RORγt) were measured via western blot (WB), quantitative real-time PCR (RT-qPCR), and immunohistochemistry analyses. Components of the vitamin A metabolic pathway (vitamin A, retinol, retinoic acid) and Treg/Th17 cell-related cytokines (IL-10, IL-17, IL-21) were evaluated using ELISA. Flow cytometry was performed to determine the percentages of Treg and Th17 cells.
The action targets of Kuijieling were significantly associated with T cell activation, Th17 cell differentiation and the immune response. IL-2, IL-6, STAT3 and RARα displayed strong binding affinities with the main components of Kuijieling, suggesting an important role in its therapeutic efficacy. Kuijieling promoted vitamin A metabolism and RA/RARα signaling in UC rats and T lymphocytes. Moreover, Kuijieling effectively regulated the Treg/Th17 cell balance in UC rats and T lymphocytes and relieved inflammation. The protective effect of Kuijieling was weakened after inhibition of the RA/RARα signaling pathway.
Kuijieling promotes vitamin A metabolism and RA synthesis, enhances interactions between RA, intracellular binding protein CRABPII and nuclear receptor RARα, and upregulates Smad3 and Foxp3, thus promoting Treg differentiation. Simultaneously, Kuijieling inhibited expression of IL-6R and IL-23R genes and production of RORγt, leading to suppression of Th17 differentiation, and ultimately, reduction of the Th17/Treg cell ratio.
药效学研究:溃疡性结肠炎(UC)是一种特发性肠道疾病,以慢性炎症为特征,病因不明。溃结灵汤是一种对溃疡性结肠炎具有独特疗效的中药。
目的:验证溃结灵汤对维生素 A 代谢和视黄酸(RA)生成的影响,评估其免疫调节活性,并进一步阐明 Treg/Th17 调节的上游机制,以阐明其对 UC 的治疗作用。
材料与方法:采用网络药理学和分子对接分析预测溃结灵的潜在抗 UC 靶点及相关通路。采用三硝基苯磺酸(TNBS)诱导大鼠结肠炎模型,诱导炎症。采用 TGF-β1、IL-6 和 IL-23 联合刺激诱导 T 淋巴细胞分化为 Th17。采用 Western blot(WB)、实时定量 PCR(RT-qPCR)和免疫组化分析检测 RA/RARα 相关因子(RARα、CRABPII、Smad3、IL-6R 和 IL-23R)和 Treg/Th17 细胞相关因子(Foxp3、RORγt)的表达水平。采用 ELISA 法检测维生素 A 代谢途径(维生素 A、视黄醇、视黄酸)和 Treg/Th17 细胞相关细胞因子(IL-10、IL-17、IL-21)的水平。采用流式细胞术检测 Treg 和 Th17 细胞的百分比。
结果:溃结灵的作用靶点与 T 细胞激活、Th17 细胞分化和免疫反应密切相关。IL-2、IL-6、STAT3 和 RARα 与溃结灵的主要成分具有较强的结合亲和力,提示其在治疗效果中具有重要作用。溃结灵促进 UC 大鼠和 T 淋巴细胞中维生素 A 代谢和 RA/RARα 信号转导。此外,溃结灵可有效调节 UC 大鼠和 T 淋巴细胞中 Treg/Th17 细胞平衡,缓解炎症。抑制 RA/RARα 信号通路后,溃结灵的保护作用减弱。
结论:溃结灵促进维生素 A 代谢和 RA 合成,增强 RA、细胞内结合蛋白 CRABPII 和核受体 RARα 之间的相互作用,上调 Smad3 和 Foxp3,从而促进 Treg 分化。同时,溃结灵抑制 IL-6R 和 IL-23R 基因表达和 RORγt 的产生,抑制 Th17 分化,最终降低 Th17/Treg 细胞比例。